DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner June 15, 2021 DPP4 Inhibitors vs GLP-1 Agonists There are no guidelines that support the combined use of a GLP1 agonist and a DPP4 inhibitor
For example, many oral versions of peptides (like BPC-157 and Thymosin Beta 4) are not bannedits just the injectables
Wegovy injection sites: where to inject Wegovy There are three recommended Wegovy injection sites on the body : Stomach: The lower abdomen is one of the easiest sites to access for self-injection, and it has a good amount of subcutaneous fat, which can help ensure proper absorption of the medication
Options that may be considered include: Vitamin B6 (pyridoxine) May provide mild relief at recommended doses
It works by reducing appetite, increasing feelings of fullness, and slowing down stomach emptying, which helps you eat less and lose weight
If you have any existing concerns regarding your kidney function, it is important to speak with a healthcare provider before starting any new supplement